<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T2" position="float">
 <label>Table 2</label>
 <caption>
  <p>Grading criteria for safety level of the treatments and its evidence.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top" align="left" rowspan="1" colspan="1">Grade</th>
    <th valign="top" align="center" rowspan="1" colspan="1">Type of adverse effects</th>
    <th valign="top" align="center" rowspan="1" colspan="1">Evidence levels quality/Type of evidence*</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <bold>High</bold>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">A. Other/s than those listed below (B-F). May include allergies, contraindication in pregnancy/lactation, children/elderly, GI disturbances, etc.</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <bold>Ia</bold> Evidence obtained from pharmacovigilance data
     <break/>
     <bold>Ib</bold> Evidence obtained from medically reviewed drug monographs/Patients information leaflets
     <break/>
     <bold>Ic</bold> Evidence obtained from clinical trials
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <bold>Medium</bold>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">B. Reported interactions which may affect cardiovascular and/or platelet function
     <break/>C. Presence of compounds potentially able to theoretically produce any in the COVID-19 context (such as coumarins, salicin, ephedrine, etc.)
     <break/>D. No adverse effects reported but known immunostimulant activities
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <bold>II</bold> Evidence obtained from case reports or clinical practice/well stablished use.
     <break/>
     <bold>III</bold> Preclinical evidence in relevant experimental models.
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <bold>Low</bold>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">E. Reported adverse effects which may affect the respiratory function
     <break/>F. Reported interactions which may affect emergency treatments (anesthesia, mechanical ventilation, etc.)
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <bold>IV</bold> Recommendations from expert committee reports or opinions of respected authorities.
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>*Adapted from General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine World Health Organization (
   <xref rid="B506" ref-type="bibr">WHO, 2000</xref>).
  </p>
 </table-wrap-foot>
</table-wrap>
